Found 12 matching trials
Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence
PHASE1This study will assess the bioequivalence (BE) of Lesinurad/Allopurinol Fix...
Location
Multiple Locations
Single and Multiple Dose Study in Japanese
PHASE1This study will explore the safety, tolerability, and serum uric acid lower...
Location
Multiple Locations
Lesinurad and Allopurinol Combination Extension Study in Gout
PHASE3This study will assess the serum uric acid lowering effects and safety of l...
Location
Multiple Locations
Combining Lesinurad With Allopurinol in Inadequate Responders
PHASE3This study that compare the serum uric acid lowering effects, clinical bene...
Location
Multiple Locations
Combining Lesinurad With Allopurinol in Inadequate Responders
PHASE3This study will compare the serum uric acid lowering effects, clinical bene...
Location
Multiple Locations
Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
PHASE3This study will compare the serum uric acid lowering effects, clinical bene...
Location
Multiple Locations
Allopurinol Combination Study
PHASE2To compare the proportion of subjects whose serum urate (sUA) levels are \<...
Location
Multiple Locations
A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
PHASE4This study evaluates the safety and efficacy of lesinurad administered with...
Location
Central Alabama Research
Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence.
PHASE1To assess the bioequivalence between lesinurad/allopurinol 200/300 FDC tabl...
Location
CAEP - Centro Avançado de Estudos e Pesquisas Ltda.
Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability
PHASE1This study will assess relative bioavailability of lesinurad/allopurinol fi...
Location
Multiple Locations